Top 20 of Lymphoma, T-Cell

Article title # Publications/# Citations

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

1994: PMBanks; JKChan; MLCleary; CDe Wolf-Peeters; GDelsol; BFalini; KCGatter; NLHarris; ESJaffe; HStein;


Epstein-Barr virus: 40 years on.

2004: ABRickinson; LSYoung;


WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

1994: MBurrell; CECanman; WSEl-Deiry; JWHarper; DEHill; JJackman; PMO'Connor; JAPietenpol; VEVelculescu; YWang;


Induction of tumors in mice by genomic hypomethylation.

2003: JDausman; AEden; FGaudet; JWGray; JGHodgson; LJackson-Grusby; RJaenisch; HLeonhardt;


Celiac disease.

2007: CCellier; PHGreen;


High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.

1998: JLde la Pompa; Idel Barco Barrantes; AJElia; MFukumoto; AHo; AItie; WKhoo; TWMak; ... TSasaki; VStambolic; ASuzuki; AWakeham;


Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.

1996: RTAbraham; GJBrunn; JCLawrence; CSabers; GWiederrecht; JWilliams;


Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.

1996: JCAster; DBaltimore; RPHasserjian; WSPear; MLScott; JSklar; BSoffer;


Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers.

2007: JAster; CBrennan; PJCampbell; LChin; BChoudhury; RADePinho; VDuke; SEdkins; ... BFeng; AKFielding; LForoni; PAFutreal; AHGoldstone; AGutierrez; GHisten; EIvanova; SJiang; OKabbarah; ELin; ATLook; VMani; MMansour; ESMartin; RSMaser; KMcNamara; CNogueira; JO'Neil; IPerna; AProtopopov; JMRowe; CStevens; MRStratton; YAWang; RWiedemeyer; KKWong; SZaghlul;


Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.

1995: RTAbraham; GJBrunn; FJDumont; MMMartín; CJSabers; GWiederrecht; JMWilliams;


T cell-specific loss of Pten leads to defects in central and peripheral tolerance.

2001: MFukumoto; THiguchi; TKaisho; YKimura; SKoyasu; TWMak; TNakano; PSOhashi; ... TOhteki; JMPenninger; TSasaki; ASuzuki; TTsubata; AWakeham; MTYamaguchi; RYoshida;


DNA-based immunization by in vivo transfection of dendritic cells.

1996: CMCelluzzi; CCondon; LDFalo; KThompson; SCWatkins;


A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen.

1993: NItoh; SNagata;


E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas.

1997: GBain; JChun; IEngel; BHuey; CMurre; DPinkel; ECRobanus Maandag; LLSharp; HPte Riele; JRVoland;


Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.

1997: HChen; CJGordon; HHeath; JHumblias; NKassam; GLarosa; CRMackay; JPMoore; ... MParmentier; NRuffing; MSamson; LWu;


Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins.

1994: ABerns; JGCollard; GGHabets; EHScholtes; JCStam; RAvan der Kammen; DZuydgeest;


The anaplastic lymphoma kinase in the pathogenesis of cancer.

2008: CAmbrogio; RChiarle; GInghirami; RPiva; CVoena;


Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.

1993: BBenacerraf; KClark; MKovacsovics-Bankowski; KLRock;


DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.

1994: SCory; AWHarris; TJacks; AStrasser;


Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.

2005: HCai; RChiarle; GDhall; GInghirami; JGKarras; DELevy; RRaz; WJSimmons; AZamò;